Skip to content Skip to sidebar Skip to footer
Subscribe Now
ThoughtSpot_Carla Adams
THOUGHTSPOT

Pharmacists and Nurses: Working Together for Better Medication Adherence

According to a study, nearly half of all patients with chronic illnesses struggle to take their medications as prescribed, leading to preventable complications, emergency room visits, and, in some cases, hospital admissions. Poor adherence to medications can compromise treatment effectiveness, leading to longer recovery times or, worse, worsening health conditions. It’s clear that healthcare providers…
November 6, 20240Comments

Read more

Key Biosimilars Events of October 2024
INSIGHTS+

Key Biosimilars Events of October 2024

Shots:      Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency       Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and patients       The major highlights were the US FDA’s approval of Dong-A ST’s Imuldosa…
November 5, 20240Comments

Read more

Viewpoints_Fred Aslan
VIEWPOINTS

Enhancing Care with NK Cell Therapy: Fred Aslan from Artiva Biotherapeutics in Conversation with PharmaShots

Shots: Immune reset in oncology has been observed with approved autologous CAR-T products. A recent study published in Nature demonstrated B-cell reconstitution and immune reset in systemic lupus erythematosus (SLE) patients treated with a CD19 autologous CAR-T, showcasing promising potential in autoimmune diseases Today, at PharmaShots, we have Fred Aslan shedding light on Artiva's AlloNK,…
November 4, 20240Comments

Read more

Alvotech & Advanz Pharma
News

Alvotech and Advanz Pharma Reports the EMA’s MAA Acceptance of AVT05 (Biosimilar, Simponi) 

Shots: The EMA has accepted the MAA of AVT05, biosimilar version of J&J's Simponi & Simponi Aria (golimumab), for the treatment of several chronic inflammatory diseases, with the decision expected in Q4’25 Alvotech, in Apr 2024, reported top-line data from a confirmatory trial of AVT05 vs Simponi in patients with moderate to severe rheumatoid arthritis,…
November 4, 20240Comments

Read more

Prescription Drugs Top 20 2024
TOP 20

Top 20 Prescription Drugs of 2024

Shots:Driven by an endless pursuit of innovation, the biopharma industry is working tirelessly to bring new-age therapies to patients with serious health conditions and lifestyle-influenced diseasesIn 2023, the global prescription drug market size was valued at $1162.61B and is anticipated to reach $2151.63B by 2032 registering a CAGR of 7.1 %. Keytruda ranks 1st…
October 31, 20240Comments

Read more

News

Meitheal Pharmaceuticals Receives Exclusive Commercial Rights of Three Biosimilars Across the US 

Shots: Meitheal Pharmaceuticals & its parent, Hong Kong King-Friend Industry (HKF), have entered into an exclusive licensing agreement for commercializing biosimilars of pegfilgrastim & filgrastim in oncology and follitropin alpha for fertility treatment in the US Pegfilgrastim (SC, once per cycle) & filgrastim (SC, IV, daily for 14 days in CT treatment cycle) are bone…
October 31, 20240Comments

Read more

Viewpoints_Adityo Prakash
VIEWPOINTS

AI in Drug Discovery: Adityo Prakash from Verseon in an Illuminating Dialogue Exchange with PharmaShots

Shots: AI is widely used in drug discovery and clinical research to find innovative cures for several debilitating conditions with unmet healthcare needs Most of the AI architecture employs deep learning that requires extensive training data sets to produce reliable predictive models Today, at PharmaShots, we have Adityo Prakash, CEO of Verseon, addressing the challenges…
October 30, 20240Comments

Read more

News

Serum Institute of India Reports the CHMP’s Positive Opinion of Siiltibcy as a Diagnostic Aid for Mycobacterium Tuberculosis Infection 

Shots:   The CHMP has recommended Siiltibcy (0.5μg/mL rdESAT-6 & rCFP-10) to diagnose Mycobacterium tuberculosis infection in individuals (age: ≥28 days), valid in the EU plus Norway, Iceland & Liechtenstein. Separate MAA will be submitted to the UK MHRA  Siiltibcy’s sensitivity & specificity was assessed in comparison with QuantiFERON TB Gold In-Tube test (QFT, in-vitro test)…
October 30, 20240Comments

Read more

ThoughtSpot_Alex Walker
THOUGHTSPOT

Best Practices for External Data Reconciliation in Healthcare

External data reconciliation involves comparing and integrating data received from external data sources, such as labs, pharmacies, insurance providers, and other healthcare organizations, with internal systems. This process ensures patient information is consistent, complete, and reliable across all platforms.  The consequences of inaccurate or inconsistent external data can be significant, ranging from billing errors…
October 28, 20240Comments

Read more